Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Sales Growth: 2007 Starts High, But Expected To Taper By Year-End

Executive Summary

BOSTON - Despite a strong start to 2007, growth in the pharmaceutical sector is expected to slow for the remainder of the year. According to IMS Health VP-Industry Relations Doug Long, "2007 has been a year that you could characterize as a fast start, slow finish.

You may also be interested in...



Niche Lobbying: Specialty Firms Form Coalition To Support Mid-Sized Pharma

A small group of mid-sized drug manufacturers are organizing an informal working group to help make their voice heard in Washington, D.C

Niche Lobbying: Specialty Firms Form Coalition To Support Mid-Sized Pharma

A small group of mid-sized drug manufacturers are organizing an informal working group to help make their voice heard in Washington, D.C

Wyeth Looks To Specialty Markets As Generics Challenge Current Model

Wyeth's R&D pipeline is evolving the firm toward more specialized areas as several of its blockbuster products face patent expirations and generic challenges

Related Content

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel